Exelixis
EXEL
#1685
Rank
$10.16 B
Marketcap
$35.61
Share price
2.24%
Change (1 day)
64.25%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company